PHLDA2: A Potential Drug Target and Biomarker (G7262)

Target Name: PHLDA2

NCBI ID: G7262

PHLDA2: A Potential Drug Target and Biomarker

Pleckstrin homology-like domain family A member 2 (PHLDA2) is a protein that has been identified as a potential drug target and biomarker. PHLDA2 is a protein that is expressed in various tissues and cells, including the brain, pancreas, and gastrointestinal tract. It is characterized by the presence of a nucleotide-binding oligomerization domain (NBD), which is a protein-coding domain that is known for its ability to form nucleotide-binding oligomerizations (NBOs).

NBOs are a type of protein-coding domain that is characterized by the presence of a nucleotide-binding oligomerization motif (NBM), which is a specific type of protein-coding domain that is capable of forming NBOs with small nucleotides such as RNA. NBMs are thought to play a key role in the regulation of gene expression and are involved in the development and progression of various diseases, including cancer.

PHLDA2 is a member of the PHLDA family, which is characterized by the presence of a nucleotide-binding oligomerization domain (NBD). The PHLDA family is thought to be involved in the regulation of various cellular processes, including cell growth, differentiation, and survival.

One of the unique features of PHLDA2 is its ability to form NBOs with small nucleotides such as RNA. This property makes PHLDA2 a potential drug target, as small nucleotides have been shown to play a key role in the regulation of gene expression and are often involved in the development and progression of various diseases.

In addition to its ability to form NBOs, PHLDA2 is also characterized by the presence of a C-terminal hypervariable region (HVR), which is a region of the protein that is capable of undergoing hypervariableity, or the ability to change in response to various environmental and genetic factors. This HVR is thought to play a key role in the regulation of PHLDA2 function and may be involved in its ability to interact with other proteins.

PHLDA2 has also been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and survival. For example, studies have shown that PHLDA2 is involved in the regulation of cell adhesion and that it plays a role in the development of cancer. In addition, PHLDA2 has also been shown to be involved in the regulation of cell migration and that it plays a role in the development of neurodegenerative diseases.

In addition to its potential drug-targeting properties, PHLDA2 has also been shown to be a potential biomarker for various diseases. For example, studies have shown that PHLDA2 is involved in the regulation of various cellular processes, including cell adhesion, migration, and survival. This suggests that PHLDA2 may be a useful biomarker for the diagnosis and treatment of various diseases.

In conclusion, PHLDA2 is a protein that has been identified as a potential drug target and biomarker. Its ability to form NBOs with small nucleotides and its involvement in the regulation of various cellular processes make it a promising target for the development of new pharmaceuticals. Further research is needed to fully understand the function of PHLDA2 and its potential as a drug target and biomarker.

Protein Name: Pleckstrin Homology Like Domain Family A Member 2

Functions: Plays a role in regulating placenta growth. May act via its PH domain that competes with other PH domain-containing proteins, thereby preventing their binding to membrane lipids (By similarity)

More Common Targets